SKL-XYZ

N/A

Report date: 2025/01/26 17:52:14
NME

Base Information

Drug NameSKL-XYZ
Drug Alias Namealpha7 nAChR partial agonist with co-agonition of Ach (SK Biopharmaceuticals)SKL-XYZ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonistsMuscarinic acetylcholine receptor agonists
TargetsNeuronal acetylcholine receptor protein alpha-7 subunitMuscarinic acetylcholine receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSK Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSK Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A